Genomic aberrations in pediatric diffuse intrinsic pontine gliomas

Area of Science:

• Pediatric Oncology
• Genomics
• Molecular Biology

Background:

• Diffuse intrinsic pontine glioma (DIPG) is a challenging pediatric brain tumor with limited tissue availability for research due to the lack of routine diagnostic biopsies.
• Understanding DIPG biology is crucial for developing effective treatments, but is hampered by the scarcity of biological samples.

Purpose of the Study:

• To assess the feasibility of performing comparative genomic hybridization (CGH) on formalin-fixed, paraffin-embedded (FFPE) autopsy specimens from pediatric patients with DIPG.
• To identify DNA copy number aberrations in DIPG using autopsy-derived FFPE tissues.
• To explore potential therapeutic targets based on identified genomic alterations.

Main Methods:

• Histological review of FFPE blocks from DIPG autopsy specimens.
• DNA extraction from tissue cores followed by labeling and hybridization to 105K oligonucleotide CGH arrays.
• Data analysis using Nexus software to identify DNA copy number abnormalities.

Main Results:

• CGH was successfully performed on 18 of 22 autopsy samples from 11 of 13 DIPG patients.
• All successfully analyzed samples exhibited DNA copy number abnormalities, including amplification of oncogenes and deletion of tumor suppressor genes.
• Significant genomic heterogeneity was observed, with aberrations in potential drug targets identified.

Conclusions:

• Comparative genomic hybridization on FFPE autopsy tissue is a feasible method for genomic DNA analysis in DIPG.
• The study identified actionable targets for molecular targeted therapy in DIPG.
• Genomic analysis of autopsy samples reveals significant heterogeneity among DIPG patients, underscoring the need for personalized treatment approaches.